Am J Perinatol 2021; 38(05): 469-476
DOI: 10.1055/s-0039-1698457
Original Article

Neonatal Antiepileptic Medication Treatment Patterns: A Decade of Change

Vi T. Le
1   Center for Perinatal Research, The Research Institute at Nationwide Children's Hospital, Columbus, Ohio
,
Hibo H. Abdi
1   Center for Perinatal Research, The Research Institute at Nationwide Children's Hospital, Columbus, Ohio
,
Pablo J. Sánchez
1   Center for Perinatal Research, The Research Institute at Nationwide Children's Hospital, Columbus, Ohio
2   Department of Pediatrics, The Ohio State University, Columbus, Ohio
3   Division of Neonatology, Nationwide Children's Hospital, Columbus, Ohio
4   Division of Pediatric Infectious Diseases, Nationwide Children's Hospital, Columbus, Ohio
,
Lina Yossef
1   Center for Perinatal Research, The Research Institute at Nationwide Children's Hospital, Columbus, Ohio
,
Patricia B. Reagan
1   Center for Perinatal Research, The Research Institute at Nationwide Children's Hospital, Columbus, Ohio
5   Department of Economics, The Ohio State University, Columbus, Ohio
,
Laurel A. Slaughter
2   Department of Pediatrics, The Ohio State University, Columbus, Ohio
6   Division of Neurology, Nationwide Children's Hospital, Columbus, Ohio
,
Angela Firestine
3   Division of Neonatology, Nationwide Children's Hospital, Columbus, Ohio
,
Jonathan L. Slaughter
1   Center for Perinatal Research, The Research Institute at Nationwide Children's Hospital, Columbus, Ohio
2   Department of Pediatrics, The Ohio State University, Columbus, Ohio
3   Division of Neonatology, Nationwide Children's Hospital, Columbus, Ohio
7   Division of Epidemiology, The Ohio State University, Columbus, Ohio
› Author Affiliations
Funding This study was supported in part by K08HL121182 (Slaughter) and the Research Institute at Nationwide Children's Hospital.

Abstract

Objective This study aims to describe the frequency and characteristics of anticonvulsant medication treatments initiated in the neonatal period.

Study Design We analyzed a cohort of neonates with a seizure diagnosis who were discharged from institutions in the Pediatric Health Information System between 2007 and 2016. Adjusted risk ratios and 95% confidence intervals for characteristics associated with neonatal (≤ 28 days postnatal) anticonvulsant initiation were calculated via modified Poisson regression.

Results A total of 6,245 infants from 47 institutions were included. There was a decrease in both phenobarbital initiation within the neonatal period (96.9 to 91.3%, p = 0.015) and continuation at discharge (90.6 to 68.6%, p <0.001). Levetiracetam (7.9 to 39.6%, p < 0.001) initiation within the neonatal period and continuation at discharge (9.4 to 49.8%, p < 0.001) increased. Neonates born at ≥ 37 weeks' gestation and those diagnosed with intraventricular hemorrhage, ischemic/thrombotic stroke, other hemorrhagic stroke, and hypoxic ischemic encephalopathy (HIE) had a higher probability of anticonvulsant administration. The most prevalent diagnosis was HIE (n = 2,223, 44.4%).

Conclusion Phenobarbital remains the most widely used neonatal seizure treatment. Levetiracetam is increasingly used as a second line therapy. Increasing levetiracetam use indicates a need for additional study to determine its effectiveness in reducing seizure burden and improving long-term outcomes.

Supplementary Material



Publication History

Received: 07 March 2019

Accepted: 26 August 2019

Article published online:
10 October 2019

© 2019. Thieme. All rights reserved.

Thieme Medical Publishers, Inc.
333 Seventh Avenue, 18th Floor, New York, NY 10001, USA

 
  • References

  • 1 Glass HC, Shellhaas RA, Wusthoff CJ. et al; Neonatal Seizure Registry Study Group. Contemporary profile of seizures in neonates: a prospective cohort study. J Pediatr 2016; 174: 98-103
  • 2 Uria-Avellanal C, Marlow N, Rennie JM. Outcome following neonatal seizures. Semin Fetal Neonatal Med 2013; 18 (04) 224-232
  • 3 Booth D, Evans DJ. Anticonvulsants for neonates with seizures. Cochrane Database Syst Rev 2004; (04) CD004218
  • 4 Blume HK, Garrison MM, Christakis DA. Neonatal seizures: treatment and treatment variability in 31 United States pediatric hospitals. J Child Neurol 2009; 24 (02) 148-154
  • 5 Ahmad KA, Desai SJ, Bennett MM. et al. Changing antiepileptic drug use for seizures in US neonatal intensive care units from 2005 to 2014. J Perinatol 2017; 37 (03) 296-300
  • 6 Slaughter LA, Patel AD, Slaughter JL. Pharmacological treatment of neonatal seizures: a systematic review. J Child Neurol 2013; 28 (03) 351-364
  • 7 Bartha AI, Shen J, Katz KH. et al. Neonatal seizures: multicenter variability in current treatment practices. Pediatr Neurol 2007; 37 (02) 85-90
  • 8 Shellhaas RA, Chang T, Wusthoff CJ. et al; Neonatal Seizure Registry Study Group. Treatment duration after acute symptomatic seizures in neonates: a multicenter cohort study. J Pediatr 2017; 181: 298-301
  • 9 Evans D, Levene M. Neonatal seizures. Arch Dis Child Fetal Neonatal Ed 1998; 78 (01) F70-F75
  • 10 Low E, Boylan GB, Mathieson SR. et al. Cooling and seizure burden in term neonates: an observational study. Arch Dis Child Fetal Neonatal Ed 2012; 97 (04) F267-F272
  • 11 Srinivasakumar P, Zempel J, Wallendorf M, Lawrence R, Inder T, Mathur A. Therapeutic hypothermia in neonatal hypoxic ischemic encephalopathy: electrographic seizures and magnetic resonance imaging evidence of injury. J Pediatr 2013; 163 (02) 465-470
  • 12 Guidotti I, Lugli L, Guerra MP. et al. Hypothermia reduces seizure burden and improves neurological outcome in severe hypoxic-ischemic encephalopathy: an observational study. Dev Med Child Neurol 2016; 58 (12) 1235-1241
  • 13 Zou GY, Donner A. Extension of the modified Poisson regression model to prospective studies with correlated binary data. Stat Methods Med Res 2013; 22 (06) 661-670
  • 14 Williams RL. A note on robust variance estimation for cluster-correlated data. Biometrics 2000; 56 (02) 645-646
  • 15 Shankaran S, Laptook AR, Ehrenkranz RA. et al; National Institute of Child Health and Human Development Neonatal Research Network. Whole-body hypothermia for neonates with hypoxic-ischemic encephalopathy. N Engl J Med 2005; 353 (15) 1574-1584
  • 16 Jacobs SE, Berg M, Hunt R, Tarnow-Mordi WO, Inder TE, Davis PG. Cooling for newborns with hypoxic ischaemic encephalopathy. Cochrane Database Syst Rev 2013; (01) CD003311
  • 17 Massaro AN, Murthy K, Zaniletti I. et al. Short-term outcomes after perinatal hypoxic ischemic encephalopathy: a report from the Children's Hospitals Neonatal Consortium HIE focus group. J Perinatol 2015; 35 (04) 290-296
  • 18 El-Dib M, Soul JS. The use of phenobarbital and other anti-seizure drugs in newborns. Semin Fetal Neonatal Med 2017; 22 (05) 321-327
  • 19 Bittigau P, Sifringer M, Genz K. et al. Antiepileptic drugs and apoptotic neurodegeneration in the developing brain. Proc Natl Acad Sci U S A 2002; 99 (23) 15089-15094
  • 20 Maitre NL, Smolinsky C, Slaughter JC, Stark AR. Adverse neurodevelopmental outcomes after exposure to phenobarbital and levetiracetam for the treatment of neonatal seizures. J Perinatol 2013; 33 (11) 841-846
  • 21 Painter MJ, Scher MS, Stein AD. et al. Phenobarbital compared with phenytoin for the treatment of neonatal seizures. N Engl J Med 1999; 341 (07) 485-489
  • 22 Davidson JO, Wassink G, van den Heuij LG, Bennet L, Gunn AJ. Therapeutic hypothermia for neonatal hypoxic-ischemic encephalopathy - where to from here?. Front Neurol 2015; 6: 198
  • 23 Barks JD, Liu YQ, Shangguan Y, Silverstein FS. Phenobarbital augments hypothermic neuroprotection. Pediatr Res 2010; 67 (05) 532-537
  • 24 Sarkar S, Barks JD, Bapuraj JR. et al. Does phenobarbital improve the effectiveness of therapeutic hypothermia in infants with hypoxic-ischemic encephalopathy?. J Perinatol 2012; 32 (01) 15-20
  • 25 Manthey D, Asimiadou S, Stefovska V. et al. Sulthiame but not levetiracetam exerts neurotoxic effect in the developing rat brain. Exp Neurol 2005; 193 (02) 497-503
  • 26 Talos DM, Chang M, Kosaras B. et al. Antiepileptic effects of levetiracetam in a rodent neonatal seizure model. Pediatr Res 2013; 73 (01) 24-30
  • 27 Kilicdag H, Daglıoglu K, Erdogan S. et al. The effect of levetiracetam on neuronal apoptosis in neonatal rat model of hypoxic ischemic brain injury. Early Hum Dev 2013; 89 (05) 355-360
  • 28 McHugh DC, Lancaster S, Manganas LN. A systematic review of the efficacy of levetiracetam in neonatal seizures. Neuropediatrics 2018; 49 (01) 12-17
  • 29 Glass HC. Neonatal seizures: advances in mechanisms and management. Clin Perinatol 2014; 41 (01) 177-190
  • 30 Zeller B, Giebe J. Pharmacologic management of neonatal seizures. Neonatal Netw 2015; 34 (04) 239-244
  • 31 Martinello K, Hart AR, Yap S, Mitra S, Robertson NJ. Management and investigation of neonatal encephalopathy: 2017 update. Arch Dis Child Fetal Neonatal Ed 2017; 102 (04) F346-F358
  • 32 Fisher BT, Lindenauer PK, Feudtner C. In-hospital databases. In: Strom B, Kimmel SE, Hennessy S. eds. Pharmacoepidemiology. Oxford: John Wiley & Sons, Ltd; 2012: 244-258
  • 33 Boylan GB, Kharoshankaya L, Wusthoff CJ. Seizures and hypothermia: importance of electroencephalographic monitoring and considerations for treatment. Semin Fetal Neonatal Med 2015; 20 (02) 103-108